Asst. Prof. Ajalaya Teyateeti, M.D.

Division : Nuclear Medicine, Department of Radiology

Specialty groups : Nuclear Medicine

Languages : Thai, English

Field of interests : Molecular imaging, radionuclide therapy, theranostics

Education
Year
2018-2020
Visiting Scientist Department of Nuclear Medicine, Division of Diagnostic Imaging,
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
2010-2013
Nuclear Medicine Residency Department of Radiology, Faculty of Medicine Siriraj Hospital,
Mahidol University, Bangkok, Thailand
2010-2011
Clinical Sciences Mahidol University, Bangkok, Thailand
2004-2010
Doctor of Medicine Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Certifications
Year
2013
Certified Thai Board of Nuclear Medicine
2011
Diploma in Clinical Sciences
2010
Thai Medical License
Professional memberships
Year
Present
Member of Nuclear Medicine Society of Thailand
Recent publications
  1. Teyateeti A, Mahvash A, Long JP, Abdelsalam M, Avritscher R, Chasen B, Kaseb A, Kuban J, Murthy R, Odisio B, Teyateeti A, Macapinlac HA, Kappadath SC. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. J Hepatocell Carcinoma. 2020;7:117-131.
  2. Teyateeti A, Khan B, Teyateeti A, Chen B, Bridhikitti J, Pan T, Peng W, Macapinlac HA, Lu Y. Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ≤0.5 ng/mL. Nucl Med Commun. 2020;41:906-915.
  3. Teyateeti A, Teyateeti A, Macapinlac HA, Lu Y. Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment? Clin Nucl Med. 2020;45:672-678.
  4. Chen B, Bathala TK, Xu G, Teyateeti A, Chapin BF, Tang C, Tu SM, Macapinlac HA, Lu Y. Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment. Clin Nucl Med. 2020;45:349-355.
  5. Teyateeti A, Jiranantanakorn T, Teyateeti A, Pusuwan P. Numb chin syndrome: An uncommon presentation of metastatic non-small cell lung cancer diagnosed by 18F-FDG PET/CT scan. Siriraj Med J 2018;70:71-74.
  6. Teyateeti A, Teyateeti A, Pusuwan P. Impact of 18 F-FDG PET/CT scan on Management of Non-small Cell Lung Cancer Patients in Contexts of University-based Hospital in Thailand. Siriraj Med J 2018;70:169-174.
  7. Teyateeti A, Laojunun P, Iampongpaiboon P, Poon-iad N, Rojwatkarnjana S, Jiranantanakorn T, Teyateeti A. Outcome of External Beam Radiation in Differentiated Thyroid Cancer: A 10-year Experience. Siriraj Med J 2017;69:247-254.
  8. Teyateeti A, Tocharoenchai C, Muangsomboon K, Komoltri C, Pusuwan P. Comparison of Accuracy of Planar and Evolution SPECT/CT Bone Imaging in Differentiating Benign from Metastatic Bone Lesions. J Med Assoc Thai 2017; 100: 100-110.
  9. Teyateeti A, Teyateeti A, Pusuwan P. Outcome of Radioactive Iodine Ablation/ Treatment in Pathologically-Defined Low Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients. Siriraj Med J 2016;68:291-8.
  10. Teyateeti A, Kanchanapiboon P, Vasansirikul C, Komoltri C, Pusuwan P. Success Rate of Radioactive Iodine Ablation in Low-Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients. Siriraj Med J 2016;68:229-34.
  11. Teyateeti A, Maungsomboon K, Pusuwan P. A Case Report of Coexisting Graves’ Disease and Struma Ovarii. Siriraj Med J 2016;68:265-70.